OpenAI partners with a biotechnology company to deploy thousands of intelligent agents to analyze brain cell maps.

OpenAI deploys thousands of agents to analyze brain cell maps, combining high-throughput gene editing with single-cell sequencing technology to process multi-omics datasets, linking gene expression changes (DEG) to molecular mechanisms, cell type characteristics, and disease phenotypes in the literature.